ArticleJCO precision oncology2022

Transcriptomics in Tumor and Normal Lung Tissues Identify Patients With Early-Stage Non-Small-Cell Lung Cancer With High Risk of Postsurgery Recurrence Who May Benefit From Adjuvant Therapies.

Vladimir Lazar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.